Your session is about to expire
← Back to Search
ACT Program for Acute Kidney Injury
N/A
Waitlist Available
Led By Erin Barreto, PharmD, RPh
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days after hospitalization
Awards & highlights
Study Summary
This trial is testing new ways to educate and coordinate care for people who have survived Acute Kidney Injury.
Who is the study for?
This trial is for English-speaking individuals in Olmsted County who have recently been hospitalized with severe stage III Acute Kidney Injury, based on specific lab results. It's not open to those with dementia, enrolled in a Primary Care Transitions Program, expecting dismissal to nursing or hospice care, needing dialysis upon discharge, or recent transplant recipients.Check my eligibility
What is being tested?
The study is testing the 'AKI in Care Transitions (ACT) program', which aims to improve education and coordination of kidney care for patients recovering from severe acute kidney injury after they leave the hospital.See study design
What are the potential side effects?
Since this trial focuses on educational and care coordination interventions rather than medications or medical procedures, traditional side effects are not applicable. However, participants may experience stress or anxiety related to participation.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days after hospitalization
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days after hospitalization
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of subjects to complete the ACT program
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: AKI in Care Transitions (ACT) GroupExperimental Treatment1 Intervention
Subjects diagnosed with Acute Kidney Injury (AKI) during their hospital stay will participate in the ACT program which provides standardized education and assists with coordination of follow up care after hospital stay.
Group II: Usual Care GroupActive Control1 Intervention
Subjects diagnosed with Acute Kidney Injury (AKI) during their hospital stay will receive standard of care from their inpatient and outpatient care teams.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,239 Previous Clinical Trials
3,771,549 Total Patients Enrolled
11 Trials studying Acute Kidney Injury
5,803 Patients Enrolled for Acute Kidney Injury
Agency for Healthcare Research and Quality (AHRQ)FED
401 Previous Clinical Trials
6,821,712 Total Patients Enrolled
Erin Barreto, PharmD, RPhPrincipal InvestigatorMayo Clinic
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have dementia.Participants will be chosen from a list of patients with severe kidney injury during a hospital stay in Olmsted County.You are expected to go to a skilled nursing facility or hospice when you leave the hospital.You are expected to require dialysis when leaving the hospital.You had an organ transplant within the last 100 days.
Research Study Groups:
This trial has the following groups:- Group 1: AKI in Care Transitions (ACT) Group
- Group 2: Usual Care Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger